Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-011771

General Counsel sold 8,869 shares at $0.67 ($5,942)

From the SEC's structured data for this filing

Trades in this filing

Miller Edward · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-05 Sale : show line 1 in the form −8,869 $0.67 $5,942 225,363 D
Open-market sales · 8,869 sh · avg $0.67 · $5,942
Loading xslF345X05/ownership.xml…